We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

141 hedge funds and large institutions have $208M invested in Emergent Biosolutions in 2024 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 35 increasing their positions, 36 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more capital invested

Capital invested by funds: $91.6M → $208M (+$116M)

69% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 29

16% more funds holding

Funds holding: 122 → 141 (+19)

3% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 36

11.15% less ownership

Funds ownership: 69.21% → 58.06% (-11%)

47% less call options, than puts

Call options by funds: $3.09M | Put options by funds: $5.83M

Holders
141
Holders Change
+19
Holders Change %
+15.57%
% of All Funds
2.04%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
49
Increased
35
Reduced
36
Closed
29
Calls
$3.09M
Puts
$5.83M
Net Calls
-$2.74M
Net Calls Change
-$3.33M

Top Buyers

Rank Fund Capital Flow
1
American Century Companies
American Century Companies
Missouri
+$2.68M
2
CCM
Carronade Capital Management
Connecticut
+$2.37M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.77M
4
JP Morgan Chase
JP Morgan Chase
New York
+$1.62M
5
Jane Street
Jane Street
New York
+$1.58M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$13.9M
2
APM
Avidity Partners Management
Texas
-$4.83M
3
Charles Schwab
Charles Schwab
California
-$4.24M
4
State Street
State Street
Massachusetts
-$3.7M
5
Renaissance Technologies
Renaissance Technologies
New York
-$3.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
101
Wells Fargo
California
$24.1K -$80.8K -18,771 -84%
Royal Bank of Canada
102
Royal Bank of Canada
Ontario, Canada
$24K +$10.5K +2,438 +201%
Macquarie Group
103
Macquarie Group
Australia
$18.3K +$11.5K +2,680 New
NC
104
nVerses Capital
Florida
$17.7K +$11.2K +2,600 New
N
105
Natixis
France
$12.5K -$48.5K -11,273 -86%
AAP
106
Arax Advisory Partners
Colorado
$12.3K +$7.78K +1,807 New
Allspring Global Investments
107
Allspring Global Investments
North Carolina
$7.64K +$4.82K +1,121 New
GI
108
GAMMA Investing
California
$5.06K +$3.19K +742 New
FFA
109
Farther Finance Advisors
California
$4.41K +$585 +136 +28%
AEPWM
110
Atlantic Edge Private Wealth Management
Florida
$3.41K – – –
CBT
111
Central Bank & Trust
Kentucky
$3.38K – – –
MPWT
112
MassMutual Private Wealth & Trust
Connecticut
$2.8K +$1.76K +410 New
Jones Financial Companies
113
Jones Financial Companies
Missouri
$2.73K +$1.72K +400 New
JFA
114
JNBA Financial Advisors
Minnesota
$2.24K – – –
FFL
115
Financial Freedom LLC
Ohio
$2.05K – – –
US Bancorp
116
US Bancorp
Minnesota
$1.81K – – –
RFA
117
Register Financial Advisors
Georgia
$1.36K – – –
TWC
118
TD Waterhouse Canada
Ontario, Canada
$1.35K +$818 +190 New
Nisa Investment Advisors
119
Nisa Investment Advisors
Missouri
$1.35K +$852 +198 New
VCM
120
Versant Capital Management
Arizona
$1.13K – – –
MSG
121
Main Street Group
Virginia
$883 – – –
GC
122
Gould Capital
Washington
$682 – – –
SPIA
123
Steward Partners Investment Advisory
New York
$682 – – –
Pacer Advisors
124
Pacer Advisors
Pennsylvania
$512 +$65 +15 +25%
LC
125
Lindbrook Capital
California
$443 +$280 +65 New
3 4
5
6 7

EBS Hedge Fund Activity: Q2 2024 in Review

141 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q2 2024, worth a combined $208M — up 126% from $91.6M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new EBS positions and 29 closed out — a net gain of 20 holders — while 35 added to existing stakes and 36 trimmed.

The largest buyer was American Century Companies, adding an estimated $2.68M. The largest seller was BlackRock, cutting an estimated $13.9M.

  • 141 institutional investors held Emergent Biosolutions (EBS) as of Q2 2024, up from 122 in Q1 2024.
  • Funds reported $208M of Emergent Biosolutions stock for Q2 2024, up 126% quarter-over-quarter.
  • 49 funds opened new Emergent Biosolutions positions in Q2 2024 and 29 closed out, a net change of +20 holders.
  • The largest Emergent Biosolutions buyer in Q2 2024 was American Century Companies, an estimated $2.68M added.
  • The largest Emergent Biosolutions seller in Q2 2024 was BlackRock, an estimated $13.9M sold.

Based on aggregated 13F filings for Q2 2024.